Correlation Between Cue Biopharma and NRX Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and NRX Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and NRX Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and NRX Pharmaceuticals, you can compare the effects of market volatilities on Cue Biopharma and NRX Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of NRX Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and NRX Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and NRX Pharmaceuticals
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Cue and NRX is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and NRX Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRX Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with NRX Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRX Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and NRX Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and NRX Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the NRX Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 1.19 times less risky than NRX Pharmaceuticals. The stock trades about -0.1 of its potential returns per unit of risk. The NRX Pharmaceuticals is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 253.00 in NRX Pharmaceuticals on August 21, 2025 and sell it today you would lose (40.00) from holding NRX Pharmaceuticals or give up 15.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. NRX Pharmaceuticals
Performance |
| Timeline |
| Cue Biopharma |
| NRX Pharmaceuticals |
Cue Biopharma and NRX Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and NRX Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and NRX Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, NRX Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will offset losses from the drop in NRX Pharmaceuticals' long position.| Cue Biopharma vs. NRX Pharmaceuticals | Cue Biopharma vs. OUTLOOK THERAPEUTICS INC | Cue Biopharma vs. Equillium | Cue Biopharma vs. Coeptis Therapeutics |
| NRX Pharmaceuticals vs. Cue Biopharma | NRX Pharmaceuticals vs. OUTLOOK THERAPEUTICS INC | NRX Pharmaceuticals vs. Spruce Biosciences, Common | NRX Pharmaceuticals vs. Coeptis Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |